Literature DB >> 10644072

Reduction of maturation phenomenon in cerebral ischemia with CDP-choline-loaded liposomes.

M Fresta1, G Puglisi.   

Abstract

PURPOSE: Cerebral ischemia represents a serious therapeutic challenge. We investigated the therapeutic efficacy of CDP-choline-loaded liposomes against cerebral ischemia. The determination of post-ischemic brain recovery by EEG analysis was carried out to evaluate the effect of CDP-choline-loaded liposomes with respect to the free drug on the maturation of ischemic injury.
METHODS: Long-circulating unilamellar liposomes were prepared by a freeze and thaw procedure followed by an extrusion through polycarbonate membranes. Wistar rats were ischemized by bilateral clamping of the common carotid arteries. Free or liposomally entrapped drug was administered (20 mg/kg) just after ischemia and thereafter once a day for six days. Post-ischemic survival, neuronal membrane peroxidation and brain recovery (EEG analysis) were evaluated.
RESULTS: The post-ischemic reperfused rats treated with CDP-choline-loaded liposomes showed a higher survival rate than animals treated with the free drug. The delayed cerebral neurodegenerative injury due to an ischemic event, referred to as maturation phenomenon, was substantially reduced with the administration of the liposomal formulation. The liposomal carrier showed a marked protection against lipoperoxidative damage.
CONCLUSIONS: Liposomes ensured a rapid recovery of the damaged membranous structure of the neuronal cells, allowing a significant improvement of brain functionality. The reduction of the maturation phenomenon may probably be of particular importance in humans, where a fundamental problem is the quality of life after an ischemic event.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10644072     DOI: 10.1023/a:1018999225435

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  30 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

Authors:  G Rouser; S Fkeischer; A Yamamoto
Journal:  Lipids       Date:  1970-05       Impact factor: 1.880

3.  Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia.

Authors:  M Kakihana; N Fukuda; M Suno; A Nagaoka
Journal:  Stroke       Date:  1988-02       Impact factor: 7.914

4.  Selective neuronal vulnerability following transient cerebral ischemia in the gerbil: distribution and time course.

Authors:  T Araki; H Kato; K Kogure
Journal:  Acta Neurol Scand       Date:  1989-12       Impact factor: 3.209

5.  Calcium accumulation and neuronal damage in the rat hippocampus following cerebral ischemia.

Authors:  J K Deshpande; B K Siesjö; T Wieloch
Journal:  J Cereb Blood Flow Metab       Date:  1987-02       Impact factor: 6.200

6.  Inhibitory effects of ebselen on lipid peroxidation in rat liver microsomes.

Authors:  M Hayashi; T F Slater
Journal:  Free Radic Res Commun       Date:  1986

7.  Enhanced therapeutic effect of cytidine-5'-diphosphate choline when associated with GM1 containing small liposomes as demonstrated in a rat ischemia model.

Authors:  M Fresta; E Wehrli; G Puglisi
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

8.  Mild intraischemic hypothermia reduces postischemic hyperperfusion, delayed postischemic hypoperfusion, blood-brain barrier disruption, brain edema, and neuronal damage volume after temporary focal cerebral ischemia in rats.

Authors:  H Karibe; G J Zarow; S H Graham; P R Weinstein
Journal:  J Cereb Blood Flow Metab       Date:  1994-07       Impact factor: 6.200

9.  Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs.

Authors:  M Fresta; G Cavallaro; G Giammona; E Wehrli; G Puglisi
Journal:  Biomaterials       Date:  1996-04       Impact factor: 12.479

10.  Liposomally-entrapped ATP: improved efficiency against experimental brain ischemia in the rat.

Authors:  A Laham; N Claperon; J J Durussel; E Fattal; J Delattre; F Puisieux; P Couvreur; P Rossignol
Journal:  Life Sci       Date:  1987-05-18       Impact factor: 5.037

View more
  8 in total

1.  CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in stroke.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher; K Tureyen
Journal:  Brain Res       Date:  2005-10-05       Impact factor: 3.252

Review 2.  Targeting the brain: rationalizing the novel methods of drug delivery to the central nervous system.

Authors:  Shailendra Joshi; Eugene Ornstein; Jeffrey N Bruce
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 3.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

Review 4.  Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disorders.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

5.  Citicoline protects brain against closed head injury in rats through suppressing oxidative stress and calpain over-activation.

Authors:  Ke Qian; Yi Gu; Yumei Zhao; Zhenzong Li; Ming Sun
Journal:  Neurochem Res       Date:  2014-04-02       Impact factor: 3.996

Review 6.  Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier.

Authors:  Débora B Vieira; Lionel F Gamarra
Journal:  Int J Nanomedicine       Date:  2016-10-18

Review 7.  Liposomes and nanotechnology in drug development: focus on neurological targets.

Authors:  Pedro Ramos-Cabrer; Francisco Campos
Journal:  Int J Nanomedicine       Date:  2013-03-03

8.  Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells.

Authors:  Marilena Celano; Maria Grazia Calvagno; Stefania Bulotta; Donatella Paolino; Franco Arturi; Domenicoantonio Rotiroti; Sebastiano Filetti; Massimo Fresta; Diego Russo
Journal:  BMC Cancer       Date:  2004-09-13       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.